318 related articles for article (PubMed ID: 23335286)
41. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
[TBL] [Abstract][Full Text] [Related]
42. Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.
Ohashi K; Nakajima Y; Kanehiro H; Tsutsumi M; Taki J; Aomatsu Y; Yoshimura A; Ko S; Kin T; Yagura K
Gastroenterology; 1995 Nov; 109(5):1612-7. PubMed ID: 7557145
[TBL] [Abstract][Full Text] [Related]
43. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria.
Zen Y; Adsay NV; Bardadin K; Colombari R; Ferrell L; Haga H; Hong SM; Hytiroglou P; Klöppel G; Lauwers GY; van Leeuwen DJ; Notohara K; Oshima K; Quaglia A; Sasaki M; Sessa F; Suriawinata A; Tsui W; Atomi Y; Nakanuma Y
Mod Pathol; 2007 Jun; 20(6):701-9. PubMed ID: 17431410
[TBL] [Abstract][Full Text] [Related]
44. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
45. Histopathological evidence of intrahepatic cholangiocarcinoma occurring in ductal plate malformation: A clinicopathologic study of 5 cases.
Wang Q; Xu Y; Wang SM; Hu AY; Pan YC; Zhang SH
Ann Diagn Pathol; 2021 Dec; 55():151828. PubMed ID: 34571341
[TBL] [Abstract][Full Text] [Related]
46.
Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
[TBL] [Abstract][Full Text] [Related]
47. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
48. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
49. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions.
Harada K; Zen Y; Kanemori Y; Chen TC; Chen MF; Yeh TS; Jan YY; Masuda S; Nimura Y; Takasawa S; Okamoto H; Nakanuma Y
Hepatology; 2001 May; 33(5):1036-42. PubMed ID: 11343228
[TBL] [Abstract][Full Text] [Related]
50. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S
Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268
[TBL] [Abstract][Full Text] [Related]
51. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
52. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
53. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
54. Pathological survey of precursor lesions in cholangiocarcinoma.
Nakanuma Y; Sugino T; Kakuda Y; Nomura Y; Watanabe H; Terada T; Sato Y; Ohnishi Y; Fukumura Y
J Hepatobiliary Pancreat Sci; 2023 Jul; 30(7):893-903. PubMed ID: 36707055
[TBL] [Abstract][Full Text] [Related]
55. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
[TBL] [Abstract][Full Text] [Related]
56. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
[TBL] [Abstract][Full Text] [Related]
57. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
[TBL] [Abstract][Full Text] [Related]
58. PBRM1 loss is a late event during the development of cholangiocarcinoma.
Luchini C; Robertson SA; Hong SM; Felsenstein M; Anders RA; Pea A; Nottegar A; Veronese N; He J; Weiss MJ; Capelli P; Scarpa A; Argani P; Kapur P; Wood LD
Histopathology; 2017 Sep; 71(3):375-382. PubMed ID: 28394406
[TBL] [Abstract][Full Text] [Related]
59. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
60. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
